Money
Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals....
Hi, what are you looking for?
Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals....
Tireless activist investor Bill Ackman of Pershing Square Capital Management announced that he is proposing an initial public offering on the London Stock Exchange...
Bill Ackman, in his obsessive, Ahab-like quest to force Botox-maker Allergan (AGN) to acquiesce to a hostile $54 billion takeover bid from Valeant (VRX),...
Hedge fund manager Bill Ackman, who runs Pershing Square Capital, made more than $144 million on his Burger King stake this morning before...
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
Bill Ackman is on the attack again, and this time, the target is the U.S. government. We thought Herbalife (HLF) was worried with Bill...
Bill Ackman is reportedly making plans to raise $4 billion for a close-end fund on the London Stock Exchange, following the lead of...
– Allergan’s newest strategy to fend off a $51 billion hostile takeover bid from Valeant Pharmaceuticals involves filing a suit in a California...
– Herbalife is famously fraught with conflict which is as much about personalities as it is about money. Hedge fund manager Bill Ackman is...
– Bill Ackman’s $1 Billion short of Herbalife is in jeopardy after his Attempt to bring it down failed. – Bill Ackman set out...